12 Health Care Stocks Moving In Wednesday's After-Market Session

In Wednesday's after-market session, several health care stocks experienced notable movements. BioAtla (NASDAQ:BCAB) rose by 11.0% to $5.00, while CareDx (NASDAQ:CDNA) increased by 10.52% to $19.42. Other gainers included Beyond Air (NASDAQ:XAIR) up 9.1%, EUDA Health Holdings (NASDAQ:EUDA) up 8.87%, and Actuate Therapeutics (NASDAQ:ACTU) up 8.37%. Conversely, QuidelOrtho (NASDAQ:QDEL) saw a significant drop of 22.8% to $13.50, with NexGel (NASDAQ:NXGL) and Vivos Therapeutics (NASDAQ:VVOS) also declining. Overall, the session highlighted both gains and losses in the health care sector.

Gainers

BioAtla (NASDAQ:BCAB) stock moved upwards by 11.0% to $5.0 during Wednesday's after-market session. The company's market cap stands at $7.0 million.
CareDx (NASDAQ:CDNA) shares moved upwards by 10.52% to $19.42. The company's market cap stands at $938.3 million.
Beyond Air (NASDAQ:XAIR) stock moved upwards by 9.1% to $0.55. The market value of their outstanding shares is at $6.0 million.
EUDA Health Holdings (NASDAQ:EUDA) stock moved upwards by 8.87% to $6.99. The company's market cap stands at $17.3 million.
Actuate Therapeutics (NASDAQ:ACTU) shares increased by 8.37% to $2.33. The company's market cap stands at $49.3 million.
American Shared Hospital (AMEX:AMS) stock moved upwards by 7.75% to $1.39. The market value of their outstanding shares is at $8.4 million.

Losers

QuidelOrtho (NASDAQ:QDEL) stock fell 22.8% to $13.5 during Wednesday's after-market session. The company's market cap stands at $1.1 billion.
NexGel (NASDAQ:NXGL) shares decreased by 9.79% to $0.68. The market value of their outstanding shares is at $5.0 million.
Vivos Therapeutics (NASDAQ:VVOS) stock decreased by 7.49% to $1.36. The market value of their outstanding shares is at $15.9 million. As per the press release, Q4 earnings came out today.
Wellgistics Health (NASDAQ:WGRX) shares decreased by 7.46% to $0.14. The market value of their outstanding shares is at $18.3 million.
Propanc Biopharma (NASDAQ:PPCB) shares decreased by 7.24% to $0.1. The company's market cap stands at $2.1 million.
Pasithea Therapeutics (NASDAQ:KTTA) stock declined by 7.23% to $0.69. The company's market cap stands at $17.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Gainers

BioAtla (NASDAQ:BCAB) stock moved upwards by 11.0% to $5.0 during Wednesday's after-market session. The company's market cap stands at $7.0 million.
CareDx (NASDAQ:CDNA) shares moved upwards by 10.52% to $19.42. The company's market cap stands at $938.3 million.
Beyond Air (NASDAQ:XAIR) stock moved upwards by 9.1% to $0.55. The market value of their outstanding shares is at $6.0 million.
EUDA Health Holdings (NASDAQ:EUDA) stock moved upwards by 8.87% to $6.99. The company's market cap stands at $17.3 million.
Actuate Therapeutics (NASDAQ:ACTU) shares increased by 8.37% to $2.33. The company's market cap stands at $49.3 million.
American Shared Hospital (AMEX:AMS) stock moved upwards by 7.75% to $1.39. The market value of their outstanding shares is at $8.4 million.

Losers

QuidelOrtho (NASDAQ:QDEL) stock fell 22.8% to $13.5 during Wednesday's after-market session. The company's market cap stands at $1.1 billion.
NexGel (NASDAQ:NXGL) shares decreased by 9.79% to $0.68. The market value of their outstanding shares is at $5.0 million.
Vivos Therapeutics (NASDAQ:VVOS) stock decreased by 7.49% to $1.36. The market value of their outstanding shares is at $15.9 million. As per the press release, Q4 earnings came out today.
Wellgistics Health (NASDAQ:WGRX) shares decreased by 7.46% to $0.14. The market value of their outstanding shares is at $18.3 million.
Propanc Biopharma (NASDAQ:PPCB) shares decreased by 7.24% to $0.1. The company's market cap stands at $2.1 million.
Pasithea Therapeutics (NASDAQ:KTTA) stock declined by 7.23% to $0.69. The company's market cap stands at $17.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.